BDBM652595 (R*)-N5-((3-methyl-5-(8-methyl-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3- a]pyrazin-7(8H)-yl)pyridin-2-yl)methyl)isoquinoline-1,5-diamine::US20240059691, Example 1345

SMILES C[C@H]1N(CCn2c1nnc2C(F)(F)F)c1cnc(CNc2cccc3c(N)nccc23)c(C)c1

InChI Key InChIKey=WIACSVSMZOIFQN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 652595   

TargetCoagulation factor XII(Human)
Kalvista Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 652595BDBM652595(US20240059691, Example 1345 | (R*)-N5-((3-methyl-5...)
Affinity DataIC50: 55nMAssay Description:In vitro inhibition of Factor XIIa was determined using an IC50 assay based on standard literature methods (see e.g Baeriswyl et al., ACS Chem. Biol....More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent